Who Owns TScan Therapeutics, Inc. (TCRX)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$6.300008019522628e+81T
% of Float Held
1.3333840482450164e+258%
QoQ Change in Holders
+13 / -3
Price History
TCRX — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| Waldron Private Wealth LLC | New Position | +10K | +$10K |
| D. E. Shaw & Co., Inc. | New Position | +69K | +$0 |
| FEDERATED HERMES, INC. | New Position | +5K | +$0 |
| GSA CAPITAL PARTNERS LLP | New Position | +226K | +$0 |
| TWO SIGMA SECURITIES, LLC | New Position | +16K | +$0 |
| HRT FINANCIAL LP | New Position | +27K | +$0 |
| Point72 Asset Management, L.P. | New Position | +15K | +$0 |
| Vanguard Personalized Indexing Management, LLC | New Position | +15K | +$0 |
| SBI Securities Co., Ltd. | New Position | +392 | +$0 |
| MIZUHO SECURITIES USA LLC | New Position | +10K | +$0 |
| PANAGORA ASSET MANAGEMENT INC | New Position | +25K | +$0 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | New Position | +188K | +$0 |
| ACADIAN ASSET MANAGEMENT LLC | New Position | +30K | +$0 |
| UBS Group AG | Increased | +44K | +$-20.1M |
| PRUDENTIAL FINANCIAL INC | Increased | +13K | +$-20.9M |
TCRX — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| BlackRock, Inc. | Decreased | -534K | -$4.3B |
| Propel Bio Management, LLC | Closed Position | -1.9M | -$3.5B |
| Alphabet Inc. | Closed Position | -1.1M | -$2.0B |
| MORGAN STANLEY | Decreased | -622K | -$1.5B |
| TANG CAPITAL MANAGEMENT LLC | Decreased | -554K | -$1.1B |
| GEODE CAPITAL MANAGEMENT, LLC | Decreased | -6K | -$1.0B |
| MILLENNIUM MANAGEMENT LLC | Decreased | -62K | -$848.3M |
| CITADEL ADVISORS LLC | Decreased | -228K | -$711.2M |
| JPMORGAN CHASE & CO | Decreased | -204K | -$432.7M |
| BANK OF AMERICA CORP /DE/ | Decreased | -184K | -$405.9M |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | Decreased | -25K | -$255.5M |
| GOLDMAN SACHS GROUP INC | Decreased | -44K | -$238.4M |
| Militia Capital Partners, LP | Closed Position | -102K | -$185.8M |
| NORTHERN TRUST CORP | Decreased | -350 | -$179.4M |
| STIFEL FINANCIAL CORP | Decreased | -25K | -$177.3M |
Top Institutional Holders(Q4 2025)
TCRX Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 59 | $653.9M | -5 |
| Q3 2025 | 64 | $61.0B | -5 |
| Q2 2025 | 69 | $46.2B | -23 |
| Q1 2025 | 92 | $55.2B | +2 |
| Q4 2024 | 90 | $214.6B | +13 |
| Q3 2024 | 77 | $103.7T | +5 |
| Q2 2024 | 72 | $95.5T | +16 |
| Q1 2024 | 56 | $116.4T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold TCRX (TScan Therapeutics, Inc.). The largest holder is DC Funds, LP with $630.0M in shares. This quarter, 13 institutions opened new positions and 3 closed their positions.
Frequently Asked Questions
How many hedge funds own TCRX?
As of Q4 2025, 50 institutional investors report holding TCRX (TScan Therapeutics, Inc.) in their 13F filings.
Who is the largest institutional holder of TCRX?
The largest institutional holder of TCRX is DC Funds, LP with $630.0M in shares.
Is institutional ownership of TCRX increasing or decreasing?
This quarter, 13 institutions opened new positions in TCRX and 3 closed their positions.